The impact of  myelofibrosis misdiagnosis on patient outcomes  can be serious. In this M.D. Anderson study, presented at ASCO in Chicago last month, those implications were analyzed.  The original pathology reports of 560 patients, diagnosed with myelofibrosis on referral to the M.D. Anderson Cancer Center in the 2007-2011 were reviewed. (For results,  click on the chart to open a larger version in a new window.)

ASCO Revised 2013 MF (2)line

Creative Commons License
© MPNforum Quarterly Journal, 2013. This work is licensed under a Creative Commons Attribution-ShareAlike 3.0 Unported License